Platelet Transfusion Thresholds in Non-Bleeding Patients

October 29, 2026 updated by: Rehab Mohamed Abdellatif, Sohag University

Platelet Transfusion Thresholds and Clinical Outcomes in Non-Bleeding Patients Admitted to Pediatric Intensive Care Unit at Sohag University Hospitals

This is a study of platelet transfusion thresholds in patients with thrombocytopenia without bleeding and benifits of transfusion in those critically ill patients to prevent bleeding

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This is a Prospective cohort hospital-based study To determine the threashold and outcome of platelet transfusion in non bleeding critically ill children in PICU

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Rehab mohammed abdellatif ali
  • Phone Number: +201127021954
  • Email: rebom66@gmail.com

Study Locations

  • Egypt
      • Sohag, Egypt
        • Sohag University Hospital
        • Contact:
          • Rehab Mohammed Abdellatif, Pediatric residant
          • Phone Number: 01127021954
          • Email: rebom66@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Pediatric patient admitted at PICU from age of day 1- to 18-year-old.

Description

Inclusion Criteria:

  • Duration of stay in PICU [more than 24 hours].

Exclusion Criteria:

  • 1-Any patient with missing data or refusal to be in the study. 2-Patients with active bleeding. 3- Patients known to have chronic platelet disorder. 4- Patients on heparin, any anticoagulant or antiplatelet drugs.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: COHORT
  • Time Perspectives: PROSPECTIVE

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children from 1m to 18 year

Platlet transfusion thresholds and clinical outcomes in Non Bleeding patients admitted to PICU
Other: Platlet transfusion

Platelt transfusion in Non Bleeding patients admitted to pediatric intensive care unit

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Platelet transfusion .
Time Frame: 1 year
1 year

Secondary Outcome Measures

Outcome Measure
Time Frame
Bleeding.
Time Frame: 1 year
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • https://med.sohag-univ.edu.eg/main/

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 30, 2026

Primary Completion (Estimated)

September 10, 2027

Study Completion (Estimated)

September 15, 2027

Study Registration Dates

First Submitted

October 18, 2026

First Submitted That Met QC Criteria

October 29, 2026

First Posted (Actual)

November 4, 2026

Study Record Updates

Last Update Posted (Actual)

November 4, 2026

Last Update Submitted That Met QC Criteria

October 29, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Soh-Med-26-9-6MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe